D. Ghosh et al., Preimplantation embryo morphology following early luteal phase anti-nidatory treatment with mifepristone (RU486) in the rhesus monkey, HUM REPR, 15(1), 2000, pp. 180-188
The ultrastructural characteristics of peri-implantation stage embryos reco
vered on day 6 after ovulation from rhesus monkeys with or without mifepris
tone (RU486) treatment during the early luteal phase were examined in the p
resent study. Monkeys were randomly allocated to two groups; group 1 animal
s were injected s.c. with 2 ml vehicle (1:4, benzyl benzoate: olive oil, v/
v, n = 21) and group 2 animals received a single dose of mifepristone (2 mg
/kg body n eight, w/v, n = 30) in the same volume of vehicle on day 2 after
ovulation in mated cycles, On day 6 after ovulation, female monkeys of bot
h groups were laparotomized and their reproductive tracts were hushed to re
trieve preimplantation stage embryos. Embryos that showed frank degeneratio
n or desynchrony on gross microscopical examination were not included in th
e present study. Preimplantation embryo growth on day 6 after ovulation was
significantly (P < 0.05) affected in the morula-blastocyst transition stag
e in mifepristone-treated monkeys compared with that in the control group o
f monkeys, Ultrastructurally, administration of mifepristone on day 2 after
ovulation depressed preimplantation stage embryo development, characterize
d by loss of cell polarity, lack of mitochondrial maturity, and lack of dif
ferentiation in trophoblast cells. Furthermore, preimplantation embryos fro
m mifepristone-treated animals displayed a higher occurrence of inter-blast
omere space, intra-cytoplasmic vacuoles, myelinoid bodies, accumulation of
lipid droplets, lysosomes, lipofuscins, autophagosomes and multivesicular b
odies. Collectively, it appears that the developmental potential of preimpl
antation embryos was significantly compromised in mifepristone-treated cycl
es.